IP Library Granted Patent US 9,816,128
Granted Patent B2
US 9,816,128 · App. 13/754,634 · Granted Nov 14, 2017

Polynucleotide marker genes and their expression, for diagnosis of endotoxemia

Inventors: Richard Bruce Brandon (Kenmore, AU); Mervyn Rees Thomas (Chapel Hill, AU)
Assignee: IMMUNEXPRESS PTY LTD
C12Q1/6809C12Q1/6883G01N33/56911C12Q2600/158G01N2800/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,816,128
App. No.
13/754,634
Granted
Nov 14, 2017
Kind
B2
Abstract

The invention discloses isolated endotoxemia marker polynucleotides selected from any one of 163 different polynucleotide sequences, or variants thereof. Endotoxemia related conditions are diagnosed in a test subject by aberrant expression of at least one of the endotoxemia markers or variants thereof. Of practical use, is the early diagnosis of disease, determining those animals at risk of developing endotoxemia, monitoring of an animals immune response to the disease and the enablement of better treatments. Of particular interest is the diagnosis of laminitis in hoofed animals, including horses.

Claims (4)

1. A composition comprising a DNA polymerase, whole peripheral blood leukocyte cDNA, wherein the peripheral blood is from a subject with a clinical sign of endotoxemia, and wherein the leukocyte cDNA comprises lysosomal associated membrane protein-1 (LAMP-1) cDNA and matrix metalloproteinase-8 (MMP-8) cDNA; and at least one oligonucleotide primer that comprises a covalently or chemically attached label and that hybridizes to LAMP-1 cDNA.

2. The composition according to claim 1 , wherein the DNA polymerase is a thermostable DNA polymerase.

3. The composition according to claim 2 , wherein the DNA polymerase is Taq polymerase.

4. The composition according to claim 1 , wherein the label comprises a fluorophore.

Assignments (2)
CHANGE OF NAME Recorded Sep 18, 2017
From: ATHLOMICS PTY LTD
To: IMMUNEXPRESS PTY LTD
Reel/Frame 043889/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 29, 2016
From: BRANDON, RICHARD BRUCE; THOMAS, MERVYN REES
To: ATHLOMICS PTY LTD
Reel/Frame 037854/0761 →
Continuity (3)
Continuation 11994996
Provisional Application 60696776 · Jul 7, 2005
Related Publication 20130210658A1 · Aug 15, 2013